The primary mission of the Protein Core is to provide protein production and purification services to the three components of this program project grant. The core will be responsible for building expression vectors, expressing and purifying recombinant proteins, submitting the proteins for production of antibodies by commercial vendors, and carrying out initial evaluation of antibodies generated to these proteins. The core will also maintain a range of bacterial and eukaryotic expression vectors and cell lines for protein production. Finally, the core will store and distribute polyclonal and monoclonal antibodies raised against the various proteins and domains purified by the core. These services will provide support to all three projects within the program. The availability of recombinant proteins will be vital to achieve the goals of all three projects within the program. Because the entire program revolves around the common theme of Notch signaling, the molecules studied in the three project components are frequently shared and overlapping. Therefore, proteins generated by the core facility can be distributed to all three project components, providing reagents to each group without duplication of effort. Similarly, the antibodies generated for detection of proteins produced by the core will also be used by all three projects. The location of the core facility, adjacent to the Blacklow laboratory where there is a wealth of existing skill in the expression and purification of recombinant proteins for biochemical and structural studies, will bring additional direct benefit to the projects to be carried out in the Aster and Pear laboratories, where there is less expertise in protein production.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA119070-05
Application #
8109425
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
5
Fiscal Year
2010
Total Cost
$114,402
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Johnson, John L; Georgakilas, Georgios; Petrovic, Jelena et al. (2018) Lineage-Determining Transcription Factor TCF-1 Initiates the Epigenetic Identity of T Cells. Immunity 48:243-257.e10
Jiang, Peng; Lee, Winston; Li, Xujuan et al. (2018) Genome-Scale Signatures of Gene Interaction from Compound Screens Predict Clinical Efficacy of Targeted Cancer Therapies. Cell Syst 6:343-354.e5
Pajcini, Kostandin V; Xu, Lanwei; Shao, Lijian et al. (2017) MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia. Sci Signal 10:
Sajed, Dipti P; Faquin, William C; Carey, Chris et al. (2017) Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma. Am J Surg Pathol 41:1473-1482
Aster, Jon C; Pear, Warren S; Blacklow, Stephen C (2017) The Varied Roles of Notch in Cancer. Annu Rev Pathol 12:245-275
Seegar, Tom C M; Killingsworth, Lauren B; Saha, Nayanendu et al. (2017) Structural Basis for Regulated Proteolysis by the ?-Secretase ADAM10. Cell 171:1638-1648.e7
Severson, Eric; Arnett, Kelly L; Wang, Hongfang et al. (2017) Genome-wide identification and characterization of Notch transcription complex-binding sequence-paired sites in leukemia cells. Sci Signal 10:
Ryan, Russell J H; Petrovic, Jelena; Rausch, Dylan M et al. (2017) A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas. Cell Rep 21:784-797
McMillan, Brian J; Tibbe, Christine; Drabek, Andrew A et al. (2017) Structural Basis for Regulation of ESCRT-III Complexes by Lgd. Cell Rep 19:1750-1757
Chiang, Mark Y; Wang, Qing; Gormley, Anna C et al. (2016) High selective pressure for Notch1 mutations that induce Myc in T-cell acute lymphoblastic leukemia. Blood 128:2229-2240

Showing the most recent 10 out of 61 publications